News

In a new study published in the journal Science, researchers outline their work that could be considered a major step towards the development of a viable vaccine for the 2019 novel coronavirus. The work was deemed so pertinent that Science expedited its review process for the study manuscript.

A protein has been discovered that is involved in the progression of a "fatty liver" to cancer. The protein "S100A11" could be harnessed as a means for early detection of cancer risk and could aid the development of new targeted therapies.

Genetic tests to predict a person’s risk of heart disease and heart attack have limited benefit over conventional testing, according to a new study.

Scientists have developed a unique smart material characterized by supersensitivity to DNA signals. It is several orders of magnitude more sensitive than the closest competitor. Moreover, the new material exhibits a higher sensitivity than that of the vast majority of currently available express DNA assays.

Diagnosing coronavirus takes approximately one hour using current methods. A new technology, based on a combination of optics and magnetic particles, can rapidly test 100 samples of patients potentially infected with the virus and reduce the diagnostic time to approximately 15 minutes.

Simple blood test could be an important new diagnostic tool for assessing suspicious ovarian growths.

A new research study will analyze blood for the presence of molecules that might predict autism risk years before symptoms appear.

Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

A new study by scientists at Imperial College London explores whether an injection of the hormone kisspeptin could be utilized in the treatment of men with sexual problems that are psychological in origin, an example being low libido.

A new CRISPR gene-editing technique prevented a genetic liver disease known to be driven by hundreds of different mutations and improved clinical symptoms in mice, Penn Medicine researchers reported in new proof-of-concept study.